Смекни!
smekni.com

Индекс массы тела и парадокс ожирения (стр. 3 из 3)

26. Sturm R., An R., Maroba J., Patel D. The effects of obesity, smoking, and excessive alcohol intake on healthcare expenditure in a comprehensive medical scheme // S. Afr. Med. J. 2013. Vol. 103(11). P. 840–844. doi: 10.7196/samj.7260.

27. Zhang J., Shi X.M., Liang X.F. Economic costs of both overweight and obesity among Chinese urban and rural residents, in 2010 // Zhonghua Liu Xing Bing XueZaZhi. 2013. Vol. 34(6). P. 598–600.

28. Gema Fru..hbeck, Hermann Toplak, Euan Woodward VolkanYumuk et al. Oppert for the Executive Committee of the European Association for the Study of Obesity Obesity: The Gateway to Ill Health – an EASO Position Statement on a Rising Public Health, Clinical and Scientific Challenge in Europe // Obes. Facts. 2013. Vol. 6. P. 117–120.

29. Calle E., Thun M.J., Petrelli J.M. et al. Body mass index and mortality in a prospective cohort of U.S. adults // N. Engl. J. Med. 1999. Vol. 341. P. 1097–1105.

30. Lakka H.M., Lakka T.A., Tuomilehto J., Salonen J.T. Abdominal obesity is associated with increased risk of acute coronary events in men // Eur. Heart J. 2002. Vol. 23. P. 706–713.

31. Шальнова С.А., Деев А.Д., Оганов Р.Г. Факторы, влияющие на смертность от сердечно-сосудистых заболеваний в российской популяции // Кардиоваскулярная терапия и профилактика. 2005. № 4(1). С. 4–9.

32. Gill M. Price, Ricardo Uauy, Elizabeth Breeze, Christopher J Bulpitt, Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death // Am. Society Clin. Nutrition. 2006. Vol. 84. P. 449–460.

33. Coutinho T., Goel K., Correa de Sa D. et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data // J. Am. Coll. Cardiol. 2011. Vol. 57. P. 1877–1886.

34. Oreopoulos A., McAlister F.A., Kalantar-Zadeh K. et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH // Eur. Heart J. 2009. Vol. 30(21). P. 2584–2592.

35. Badkeha A., Rathod A., Kizilbash M. et al. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox // Am. J. Med. 2010. Vol.123(7). P. 646–651.

36. Carnethon M.R., De Chavez P.J., Biggs M.L. et al. Association of weight status with mortality in adults with incident diabetes // JAMA. 2012. Vol. 308(6). P. 581–590.

37. Oreopoulos A., Padwal R., Kalantar-Zadeh K. et al. Body mass index and mortality in heart failure: a meta-analysis // Am. Heart J. 2008. Vol. 156(1). P.13–22.

38. Singh P.N., Clark R.W., Herring P. et al. Obesity and Life Expectancy Among Long-Lived Black Adults // J. Gerontol. A. Biol. Sci Med. Sci. 2013.

39. de Gonzalez A., Berrington, Hartge P., Cerhan J.R. et al. Body-mass index and mortality among 1.46 million white adults // N. Engl. J. Med. 2010. Vol. 363(23). P. 2211–2219.

40. Flegal K.M., Kit B.K., Orpana H., Graubard B.I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis // JAMA. 2013. Vol.309(1). P. 71–82.

41. van Kuijk J.P., Flu W.J., Galal W. et al. The influence of polyvascular disease on the obesity paradox in vascular surgery patients // J. Vasc. Surg. 2011. Vol. 53(2). P.399–406.

42. Benedetto U., Danese C., Codispoti M. Obesity paradox in coronary artery bypass grafting: Myth or reality?// J. Thorac. Cardiovasc. Surg. 2013.

43. Andersen K.K., Olsen T.S. The obesity paradox in stroke: Lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients // Int. J. Stroke. 2013.

44. Kim C.K., Ryu W.S., Kim B.J., Lee S.H. Paradoxical effect of obesity on hemorrhagic transformation after acute ischemic stroke // BMC Neurol. 2013. Vol. 23;13(1). P. 123.

45. Durazo-Arvizu R., Cooper R.S., Luke A. et al. Relative weight and mortality in U.S. blacks and whites: findings from representative national population samples // Ann. Epidemiol. 1997. Vol. 7. P. 383–395.

46. Valentijn T.M., Galal W., Tjeertes E.K. et al. The obesity paradox in the surgical population // Surgeon. 2013. Vol.11(3). P.169–176.

47. Strandberg T.E., Strandberg A.Y., Salomaa V.V. et al. Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men // Eur. Heart J. 2009. Vol.30(14). P. 1720–1727.

48. Strandberg T.E., Stenholm S., Strandberg A.Y. et al. The «Obesity Paradox,» Frailty, Disability, and Mortality in Older Men: A Prospective, Longitudinal Cohort Study // Am. J. Epidemiol. 2013.

49. Носков С., Шерина Т., Пряничникова А. О положительной роли ожирения в клинике внутренних болезней // Врач. 2013. № 4. С. 13–17.

50. Драпкина О.М., Дикур О.М. Избыточный вес и недостаток массы тела: между Сциллой и Харибдой // Артериальная гипертензия. 2009. № 5. С. 633–639.

51. Arnlöv J., Ingelsson E., Sundström J., Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men // Circulation. 2010.Vol. 121(2). P. 230–236.

52. Zafrir B., Adir Y., Shehadeh W. et al. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the «obesity paradox» // Respir. Med. 2013. Vol. 107 (1). P. 139–146.

53. Kramer C.K., Zinman B., Retnakaran R. Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta-analysis // Ann. Intern. Med. 2013. Vol. 159(11). P. 758–769.

54. Yanovski S.Z., Yanovski J.A. Long-term Drug Treatment for Obesity A Systematic and Clinical Review Published online November 14, 2013.

55. Thomsen M., Nordestgaard B.G. et al. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome // JAMA Intern. Med. 2013.

56. Coutinho T., Goel K., Corrêa de Sá D. et al. Combining Body Mass Index With Measures of Central Obesity in the Assessment of Mortality in Subjects With Coronary Disease: Role of «Normal Weight Central Obesity» // J. Am. Coll. Cardiol. 2013. Vol. 61(5). P. 553–560.

57. Lavie C.J., Milani R.V., Artham S.M. et al. The obesity paradox, weight loss, and coronary disease // Am. J. Med. 2009. Vol. 122(12). P. 1106–1114.

58. Padwal R.S., Rucker D., Li S.K. et al. Long-term drug pharmacotherapy for obesity and overweight January 21, 2009 http://summaries.cochrane.org/CD004094/

59. Norris S.L., Zhang X., Avenell A. et al. Long-term non-pharmacological weight loss interventions for adults with prediabetes January 21, 2009 http://summaries.cochrane.org/CD005270/

60. Tran P.T., Thomas A. Summary minutes of the Endocrinologic and Metabolic Drugs Advisory Committee meeting March 28–29, 2012. http://www.fda.gov/downloads/AdvisoryCommittees